Table 1.
Category | Variable | Description |
---|---|---|
Wastewater treatment plant & infrastructure | Sample location type | Primary influent, primary sludge, street line manhole, pump station, septic, on-facility (university campus, correctional facility, etc.), other |
Population served | Estimated population contributing to sample location | |
Combined or separated system? | Combined, separated, mixed | |
Primary county/municipality served | County/municipality, state/province, country | |
Flow | Mean daily flow on day(s) of for sample collection. List “N/A” if this information is not available (e.g. for sewer or building samples) | |
Sample collection | Sample collection type | Grab, composite (flow-weighted or time-weighted, including composite duration), other |
Sample matrix | Raw wastewater, pre-treated wastewater (including pre-treatment type), wastewater solids, other | |
Sample date | Date (MM/DD/YYYY) of sample collection from sewer system; if composite, composite sampling start date | |
Sample time | Time of sample collection from sewer system; if composite, composite sampling start time | |
Sample processing | Pre-concentration storage temperature | Degrees Celsius (if available), on ice, dry ice, refrigerated, frozen. Specify number of freeze–thaw cycles, if any |
Concentration method & citation | PEGa precipitation, ultrafiltration, none, HA filtration, ultracentrifugation, nanotrap beads, other; include protocol citation | |
Recovery control name & efficiency | BCoV,b BRSV,c MHV,d OC43,e other; include recovery efficiency if a control was used. List “none” if no recovery control was used | |
Extraction method & citation | Kit-based (include kit name), TRIzol, MagBead, other; include protocol citation | |
Amount of sample processed | Starting volume [mL] or mass [g] of raw sample processed | |
Extraction blanks results | Signal not detected, signal detected (% positive), blanks not used | |
Target quantification | PCR type | qPCR, dPCR, other |
SARS-CoV-2 concentrations | Concentration back-calculated to raw sample volume/mass basis (e.g. copies per L wastewater or copies per g dry weight sludge) | |
Identification of samples below LODf/LOQg | Flag as below LODf(BLOD) or below LOQg(BLOQ) | |
SARS-CoV-2 target gene(s) | Gene target and primers/assay | |
Endogenous wastewater control name & concentration | PMMoV,h crAssphage, HF183,i other; include concentration if measured. List “none” if no endogenous wastewater control was used | |
Required MIQE17/dMIQE18 guidelines | Includes specifications for assessing RNA quantification & integrity, reaction conditions, no-template controls, positive controls, assay efficiencies (for qPCR), LOD,f LOQ,g inhibition testing, and others. See references17,18 for complete lists |
Polyethylene glycol.
Bovine coronavirus.
Bovine respiratory syncytial virus.
Murine hepatitis virus.
Human coronavirus OC43.
Limit of detection.
Limit of quantification.
Pepper mild mottle virus.
Human Bacteroides marker HF183.